Linda Danielson was appointed as chief executive officer in January 2023. She joined IDDI in 2006 as statistical advisor. She became chief operating officer (COO) in 2011 and executive vice president (VP), IDDI Inc. in 2016. Ms. Danielson has been key in the operational development of the company, including its U.S. branch in Raleigh, North Carolina. Linda obtained her master’s degree in biostatistics in 1990 from the University of Wisconsin, Madison, and a bachelor’s degree in mathematics and French from St. Olaf college in Minnesota. She has over 30 years of experience in the pharmaceutical industry and in the clinical trial environment. Before coming to IDDI in 2006, Linda was the head of biostatistics at UCB Pharma in Belgium. Prior to moving to Belgium in 1993, Linda provided statistical support for the Beaver Dam Eye study at the University of Wisconsin, Madison.

Back to Team